Evinacumab - Regeneron Pharmaceuticals
At a glance
- Drug Originator Regeneron Pharmaceuticals; Sanofi
- Drug Licenced by Ultragenyx Pharmaceutical
- Drug Class Antihyperlipidaemics; Monoclonal antibodies
- Mechanism of Action ANGPTL3 protein inhibitors
- USA Patent Applicants REGENERON PHARMACEUTICALS
- USA Patents 3
- BLAs 1
- International Patents 69
Disclaimer